Cargando…

CSF1-ETS2 Induced microRNA in Myeloid Cells Promote Metastatic Tumor Growth

Metastasis of solid tumors is associated with poor prognosis and bleak survival rates. Tumor infiltrating myeloid cells (TIMs) are known to promote metastasis but the mechanisms underlying their collaboration with tumor cells remain unknown. Here we report an oncogenic role for microRNA in driving M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mathsyaraja, Haritha, Thies, Katie, Taffany, David A., Deighan, Clayton, Liu, Tom, Yu, Lianbo, Fernandez, Soledad A., Shapiro, Charles, Otero, Jose, Timmers, Cynthia, Lustberg, Maryam B., Chalmers, Jeffrey, Leone, Gustavo, Ostrowski, Michael C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4369473/ https://www.ncbi.nlm.nih.gov/pubmed/25241894 http://dx.doi.org/10.1038/onc.2014.294

Ejemplares similares

Multiparameter Evaluation of the Heterogeneity of Circulating Tumor Cells Using Integrated RNA In Situ Hybridization and Immunocytochemical Analysis
por: Wu, Yongqi, et al.
Publicado: (2016)

Generation of a pancreatic cancer model using a Pdx1-Flp recombinase knock-in allele
por: Wu, Jinghai, et al.
Publicado: (2017)

The MYC transcription factor network: balancing metabolism, proliferation and oncogenesis
por: Carroll, Patrick A., et al.
Publicado: (2018)

Heterogeneous atypical cell populations are present in blood of metastatic breast cancer patients
por: Lustberg, Maryam B, et al.
Publicado: (2014)

Ets2 in Tumor Fibroblasts Promotes Angiogenesis in Breast Cancer
por: Wallace, Julie A., et al.
Publicado: (2013)

Protective Role of Myeloid Cells Expressing a G-CSF Receptor Polymorphism in an Induced Model of Lupus
por: Sivakumar, Ramya, et al.
Publicado: (2018)

Max deletion destabilizes MYC protein and abrogates Eµ-Myc lymphomagenesis
por: Mathsyaraja, Haritha, et al.
Publicado: (2019)

Deep learning tools and modeling to estimate the temporal expression of cell cycle proteins from 2D still images
por: Pécot, Thierry, et al.
Publicado: (2022)

Stromal ETS2 Regulates Chemokine Production and Immune Cell Recruitment during Acinar-to-Ductal Metaplasia()
por: Pitarresi, Jason R., et al.
Publicado: (2016)

Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia
por: Braun, Theodore P., et al.
Publicado: (2019)

M-CSF and GM-CSF Regulation of STAT5 Activation and DNA Binding in Myeloid Cell Differentiation is Disrupted in Nonobese Diabetic Mice
por: Rumore-Maton, B., et al.
Publicado: (2008)

CSF-1 maintains pathogenic but not homeostatic myeloid cells in the central nervous system during autoimmune neuroinflammation
por: Hwang, Daniel, et al.
Publicado: (2022)

GM-CSF and the role of myeloid regulatory cells in the pathogenesis and treatment of Crohn’s disease
por: Däbritz, Jan
Publicado: (2015)

Myeloid Disease with the CSF3R T618I Mutation after CLL
por: Couto, Maria Eduarda, et al.
Publicado: (2020)

MLKL promotes cellular differentiation in myeloid leukemia by facilitating the release of G-CSF
por: Wang, Xin, et al.
Publicado: (2021)

Transvaginal perfusion of G-CSF for infertile women with thin endometrium in frozen ET program: A non-randomized clinical trial
por: Eftekhar, Maryam, et al.
Publicado: (2014)

Single-cell RNA-seq analysis of human CSF microglia and myeloid cells in neuroinflammation
por: Esaulova, Ekaterina, et al.
Publicado: (2020)

GM-CSF Nitration Is a New Driver of Myeloid Suppressor Cell Activity in Tumors
por: Calì, Bianca, et al.
Publicado: (2021)

Correction: MLKL promotes cellular differentiation in myeloid leukemia by facilitating the release of G-CSF
por: Wang, Xin, et al.
Publicado: (2021)

Author Correction: Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia
por: Braun, Theodore P., et al.
Publicado: (2022)

Power analysis for RNA-Seq differential expression studies
por: Yu, Lianbo, et al.
Publicado: (2017)

Power analysis for RNA-Seq differential expression studies using generalized linear mixed effects models
por: Yu, Lianbo, et al.
Publicado: (2020)

Triggering Receptor Expressed on Myeloid Cells-2 (TREM2) Interacts With Colony-Stimulating Factor 1 Receptor (CSF1R) but Is Not Necessary for CSF1/CSF1R-Mediated Microglial Survival
por: Cheng, Baoying, et al.
Publicado: (2021)

CSF metabolites associate with CSF tau and improve prediction of Alzheimer's disease status
por: Dong, Ruocheng, et al.
Publicado: (2021)

Assessment of γ-H2AX levels in circulating tumor cells from patients receiving chemotherapy
por: Garcia-Villa, Alejandra, et al.
Publicado: (2012)

Value of CSF-Cl, CSF-GS, CSF-MALB, and CSF-ADA in Differential Diagnosis of Secondary Hydrocephalus
por: Huang, Junzhang, et al.
Publicado: (2022)

The significance of G-CSF expression and myeloid-derived suppressor cells in the chemoresistance of uterine cervical cancer
por: Kawano, Mahiru, et al.
Publicado: (2015)

Analysis of the developmental stages, kinetics, and phenotypes exhibited by myeloid cells driven by GM-CSF in vitro
por: Rogers, Peter B., et al.
Publicado: (2017)

Divergent effects of Wnt5b on IL-3- and GM-CSF-induced myeloid differentiation
por: de Rezende, Marina Mastelaro, et al.
Publicado: (2020)

Rapamycin Promotes the Expansion of Myeloid Cells by Increasing G-CSF Expression in Mesenchymal Stem Cells
por: Li, Minghao, et al.
Publicado: (2022)

Retracted: Value of CSF-Cl, CSF-GS, CSF-MALB, and CSF-ADA in Differential Diagnosis of Secondary Hydrocephalus
por: Imaging, Contrast Media & Molecular
Publicado: (2023)

Genomic risk prediction of aromatase inhibitor‐related arthralgia in patients with breast cancer using a novel machine‐learning algorithm
por: Reinbolt, Raquel E., et al.
Publicado: (2017)

Correspondence on "G-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment" by Martinez Sanz et al
por: Mora, Jaume, et al.
Publicado: (2021)

Response to: Correspondence on "G-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment" by Mora et al
por: Martinez Sanz, Paula, et al.
Publicado: (2021)

Stromal PTEN determines mammary epithelial response to radiotherapy
por: Sizemore, Gina M., et al.
Publicado: (2018)

G-CSF and GM-CSF in clinical trials.
por: Antman, K. H.
Publicado: (1990)

Fully moderated t-statistic in linear modeling of mixed effects for differential expression analysis
por: Yu, Lianbo, et al.
Publicado: (2019)

Treatment with G-CSF reduces acute myeloid leukemia blast viability in the presence of bone marrow stroma
por: Nomdedeu, Meritxell, et al.
Publicado: (2015)

GM-CSF Quantity Has a Selective Effect on Granulocytic vs. Monocytic Myeloid Development and Function
por: Sun, Li, et al.
Publicado: (2018)

The combination of CHK1 inhibitor with G-CSF overrides cytarabine resistance in human acute myeloid leukemia
por: Di Tullio, Alessandro, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_7qr6mepbm58gvrj5omudp59sk4